From Blue Lion Musings on TG

🚩 The antiviral drug remdesivir, brand name Veklury, is approved for use against COVID-19 despite research showing it lacks effectiveness and can cause high rates of organ failure.

🚩 A study published in The Lancet found “no clinical benefit” from the use of remdesivir in hospitalized patients.

🚩 The U.S. government pays hospitals a 20% upcharge on the entire hospital bill when remdesivir is used.

If the jab doesn’t kill you, there’s remdesivir.